In this webinar Principal Scientist at Gubra Henrik Björk Hansen discusses strategies to improve clinical translatability of preclinical models of NASH. The webinar introduces a diet-induced obese and biopsy-confirmed rodent model of NASH with progressive development of fibrosis and hepatocellular carcinoma, that recapitulates the wide spectrum of the human condition.
Preclinical drug discovery in NASH – Narrowing the translational gap
Share this page
For further information
Hørsholm Kongevej 11B
+45 3152 2650